Novel nanomedicines to overcome cancer multidrug resistance
Chemotherapy remains a powerful tool to eliminate malignant cells. However, the efficacy of
chemotherapy is compromised by the frequent emergence of intrinsic and acquired …
chemotherapy is compromised by the frequent emergence of intrinsic and acquired …
Strategies and lessons learned from total synthesis of taxol
L Min, JC Han, W Zhang, CC Gu, YP Zou… - Chemical …, 2023 - ACS Publications
Taxol (paclitaxel), the most well-known taxane diterpenoid, is the best-selling natural-source
anticancer drug ever produced and one of the most common prescriptions in the treatment of …
anticancer drug ever produced and one of the most common prescriptions in the treatment of …
Therapeutic strategies to overcome taxane resistance in cancer
T Das, U Anand, SK Pandey, CR Ashby Jr… - Drug Resistance …, 2021 - Elsevier
One of the primary causes of attenuated or loss of efficacy of cancer chemotherapy is the
emergence of multidrug resistance (MDR). Numerous studies have been published …
emergence of multidrug resistance (MDR). Numerous studies have been published …
Triple negative breast cancer treatment options and limitations: future outlook
O Obidiro, G Battogtokh, EO Akala - Pharmaceutics, 2023 - mdpi.com
Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER),
progesterone receptors (PR), and human epidermal growth factor receptors (HER2). The …
progesterone receptors (PR), and human epidermal growth factor receptors (HER2). The …
Long non-coding RNA mediated drug resistance in breast cancer
Breast cancer is one of the most prevalent cancers in women and a leading cause of
mortality. As per the GLOBCAN report of 2021, breast cancer has surpassed lung cancer …
mortality. As per the GLOBCAN report of 2021, breast cancer has surpassed lung cancer …
Curcumin as an enhancer of therapeutic efficiency of chemotherapy drugs in breast cancer
R Farghadani, R Naidu - International Journal of Molecular Sciences, 2022 - mdpi.com
Female breast cancer is the world's most prevalent cancer in 2020. Chemotherapy still
remains a backbone in breast cancer therapy and is crucial in advanced and metastatic …
remains a backbone in breast cancer therapy and is crucial in advanced and metastatic …
Chemopreventive effects of hesperidin against paclitaxel-induced hepatotoxicity and nephrotoxicity via amendment of Nrf2/HO-1 and caspase-3/Bax/Bcl-2 signaling …
Paclitaxel (PTX) is a widely used chemotherapeutic drug particularly effective against lung,
breast, and ovarian cancer, though its usefulness is limited due to its multi-organ toxicity …
breast, and ovarian cancer, though its usefulness is limited due to its multi-organ toxicity …
Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors
X Du, B Yang, Q An, YG Assaraf, X Cao, J Xia - The Innovation, 2021 - cell.com
The discovery that mutations in the EGFR gene are detected in up to 50% of lung
adenocarcinoma patients, along with the development of highly efficacious epidermal …
adenocarcinoma patients, along with the development of highly efficacious epidermal …
Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies
Y Li, C Xu, B Wang, F Xu, F Ma, Y Qu, D Jiang… - Nature …, 2022 - nature.com
Chemotherapy and targeted therapy are the major treatments for gastric cancer (GC), but
drug resistance limits its effectiveness. Here, we profile the proteome of 206 tumor tissues …
drug resistance limits its effectiveness. Here, we profile the proteome of 206 tumor tissues …
Paclitaxel resistance related to nuclear envelope structural sturdiness
Abstract Taxanes (Taxol/paclitaxel, Docetaxel/taxotere) are a key group of successful drugs
commonly used in chemotherapy to treat several major malignant tumors also as a front-line …
commonly used in chemotherapy to treat several major malignant tumors also as a front-line …